Persistent trophoblast disease following partial molar pregnancy

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 46, Issue 2, 2006, Pages 119-123

  Wiesma, Sabien ^a   Kerkmeijer, Linda ^a   Bekkers, Ruud ^a   Pyman, Jan ^b   Tan, Jeffrey ^b   Quinn, Michael ^c,d  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b ROYAL WOMEN'S HOSPITAL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d NONE   (Australia)

Author keywords

Partial hydatidiform mole follow up

Indexed keywords

CHORIONIC GONADOTROPIN; FOLINIC ACID; METHOTREXATE;

ARTICLE; AUSTRALIA; CHEMOTHERAPY; CLINICAL PROTOCOL; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; FOLLOW UP; GESTATIONAL AGE; HEALTH PROGRAM; HORMONE DETERMINATION; HOSPITAL; HUMAN; HUMAN TISSUE; HYDATIDIFORM MOLE; MAJOR CLINICAL STUDY; MATERNAL AGE; OBSTETRIC OPERATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; REGISTER; RELAPSE; REMISSION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SINGLE DRUG DOSE; TROPHOBLASTIC DISEASE; TUMOR RECURRENCE;

ADULT; AUSTRALIA; CHORIONIC GONADOTROPIN; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; HYDATIDIFORM MOLE; MATERNAL AGE; METHOTREXATE; NEOPLASM RECURRENCE, LOCAL; PARITY; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY OUTCOME; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TROPHOBLASTIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UTERINE NEOPLASMS;

EID: 33645375407     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2006.00539.x     Document Type: Article

References (36)

1. Kohorn EI. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: Description and critical assessment. Int J Gynecol Cancer 2001; 11: 73-77.
2. Vassilakos P, Kajii T. Hydatidiform mole: Two entities. Lancet 1976; 1: 259.
3. Benedet JL, Bender H. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. Int J Gynecol Obstet 2000; 70: 209-262.
4. ACOG Practice Bulletin number 53. Diagnosis and treatment of gestational trophoblastic disease. Obstet Gynecol. 2004; 103: 1365-1376.
5. Vassilakos P, Riotton G, Kajii T. Hydatidiform mole: Two entities. Am J Obstet Gynecol 1977; 127: 167-170.
6. Czernobilsky B, Barash A, Lancet M. Partial mole: A clinicopathologic study of 25 cases. Obstet Gynecol 1982; 59: 75-77.
7. Goldstein DP, Berkowitz RS. Current management of complete and partial molar pregnancy. J Reprod Med 1994; 39: 139-146.
8. Rice LW, Berkowitz RS, Lage JM et al. Persistent gestational trophoblastic tumor after partial hydatidiform mole. Gynecol Oncol 1990; 36: 358-361.
9. Fine C, Bundy AL, Berkowitz RS, Boswell SB, Berezin AF, Doubilet PM. Sonographic diagnosis of partial hydatidiform mole. Obstet Gynecol 1989; 73: 414-418.
10. Szulman AE, Surti U. The syndromes of hydatidiform mole. I.Cytogenetic and morphologic correlations. Am J Obstet Gynecol 1978; 131: 665-671.
11. Paradinas FJ, Browne P, Fisher RA, Foskett M, Bagshawe KD, Newlands E. A clinical, histopathological and flow cytometric study of 149 complete moles, 146 partial moles and 107 non molar hydropic abortions. Histopath 1996; 28: 101-109.
12. Howat AJ, Beck S, Fox H et al. Can histopathologists reliably diagnose molar pregnancy? J Clin Pathol 1993; 46: 599-602.
13. Lawler SD, Pickthall VJ, Fisher RA, Povey S, Evans MW, Szulman AE. Genetic studies of complete and partial hydatidiform moles. Lancet 1979, 580.
14. Beischer NA, Bettinger HF, Fortune DW, Pepperell R. Hydatidiform mole and its complications in the state of Victoria. J Obstet Gynaecol Brit Commonw 1970; 77: 263-276.
15. Seckl MJ, Fisher RA, Salerno G et al. Choriocarcinoma and partial hydatidiform moles. Lancet 2000; 356: 36-39.
16. Delfs E. Quantitative chorionic gonadotropin: Prognostic value in hydatidiform mole and chorionepithelioma. Obstet Gynecol 1957; 9: 1-23.
17. Morrow CP, Kletsky OA, Disaia PJ, Mishell DR, Robert NM. Clinical and laboratory correlates of molar pregnancy and trophoblastic disease. Am J Obstet Gynecol 1977; 128: 424-429.
18. Schlaerth JB, Morrow CP, Kletzky OA, Nalick RH, D'Ablaing GA. Prognostic characteristics of serum human chorionic Gonadotropin titre regression following molar pregnancy. Obstet Gynecol 1981; 58: 478-482.
19. Kohorn EI. Hydatidiform mole and gestational trophoblastic disease in southern Connecticut. Obstet Gynecol 1982; 59: 78-84.
20. Yedema KA, Verheijen RH, Kenemans P et al. Identification of patients with persistent trophoblastic disease by means of a normal human Chorionic Gonadotropin regression curve. Am J Obstet Gynecol 1993; 168: 787-792.
21. National Health and Medical Research Council. When does quality assurance in health care require independent ethical review? 2003. Available from http://www.nhmrc.gov.au/publications/_les/e46.pdf (accessed 06.12.2005)
22. Olesnicky G, Long AR, Quinn MA, Pepperell RJ, Fortune DW, Kneale BLG. Hydatidiform mole in Victoria: Aetiology and natural history. Aust N Z J Obstet Gynaecol 1985; 25: 1-7.
23. Stone M, Bagshawe KD. Hydatidiform mole: Two entities. Lancet 1976; 1: 535-536.
24. Szulman AE, Ma H, Wong LC, Hsu C. Residual trophoblastic disease in association with partial hydatidiform mole. Obstet Gynecol 1981; 57: 392-394.
25. Lurain JR, Brewer JI, Torok EE, Halpern B. Natural history of hydatidiform mole after primary evacuation. Am J Obstet Gynecol 1982; 145: 591-594.
26. Franke HR, Risse EKJ, Kenemans P, Vooijs GP, Stolk JG. Epidemiologic features of hydatidiform mole in the Netherlands. Obstet Gynecol 1983; 62: 613-616.
27. Ohama K, Katsunori U, Okamoto E et al. Cytogenetic and clinicopathologic studies of partial moles. Obstet Gynecol 1986; 68: 259-262.
28. Bagshawe KD, Dent J, Webb J. Hydatidiform mole in England and Wales 1973-83. Lancet 1986; 2: 673-677.
29. Berkowitz RS. Partial molar pregnancy: A separate entity. Contemp Obstet Gynecol 1988; 31: 99-102.
30. Bagshawe KD, Lawler SD, Paradinas FJ, Dent J, Brown P, Boxer GM. Gestational trophoblastic tumors following initial diagnosis of partial hydatidiform mole. Lancet 1990; 335: 1074-1076.
31. Lage JM, Berkowitz RS, Rice LW, Goldstein DP, Bernstein MR, Weinberg DS. Flow cytometric analysis of DNA content in partial hydatidiform moles with persistent gestational trophoblastic tumor. Obstet Gynecol 1991; 77: 111 -115.
32. Goto S, Yamada A, Ishizuka T et al. Development of post-molar trophoblastic disease after partial molar pregnancy. Gynecol Oncol 1993; 48: 165-170.
33. Feltmate CM, Batorfi J, Fulop V, Goldstein DP, Doszpod J, Berkowitz RS. Human chorionic gonadotropin follow-up in patients with molar pregnancy: a time for reevaluation. Obstet Gynecol 2003; 101: 732-736.
34. Lavie I, Rao GG, Diego HC, Miller DS, Schorge JO. Duration of human chorionic gonadotropin surveillance for partial hydatidiform moles. Am J Obstet Gynecol 2005; 192: 1362-1364.
35. Wolfberg AJ, Feltmate C, Goldstein DP, Berkowitz RS, Lieberman E. Low risk of relapse after achieving undetectable hCG levels in women with complete molar pregnancy. Obstet Gynecol 2004; 104: 551-554.
36. Batorfi J, Vegh G, Szepesi J, Szigetvari I, Doszpod J, Fulop V. How long should patients be followed after molar pregnancy? Analysis of serum hCG follow-up data. Obstet Gynecol 2004; 112: 95-97.